Cramer Pamela J. sold RYTM
July 29, 2025 · Form 4 insider transaction
Cramer Pamela J. sold 1,520 shares of Rhythm Pharmaceuticals, Inc. at $85.93 per share, a transaction worth $130.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,520
Price
$85.93
Total value
$130.6K
InsiderCramer Pamela J.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 29, 2025
Filing dateJuly 29, 2025
Shares owned after20,814
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.